I first heard the term polycystic ovary syndrome when I was 18. My aunt had been diagnosed and a doctor had told her it could run in families. After hearing about her weight changes, acne, and irregular periods, I made an appointment with my primary care doctor, convinced that the same thing might be going on for me.
The visit felt routine: blood work, an ultrasound, the usual questions. So I was stunned when the doctor told me there was no way I had PCOS. Instead I was given the same advice I had heard many times before: change my diet, exercise more, lose weight, and the rest would follow. I left feeling dismissed and ashamed, as if my symptoms were a personal failing rather than a sign of something medical.
It took five years before anyone took my concerns seriously. At 23, during a routine gynecologic visit, I mentioned my family history and the issues I had been living with. This doctor actually read my records, listened to me, and simply said, of course you have PCOS. That one sentence changed everything. The relief was immediate. I stopped blaming myself for symptoms that had felt inexplicable for years.
My treatment began with metformin, which helped address insulin resistance and, over a few months, led to weight loss and improved energy. Hearing that there is no cure and that this is a condition I would manage long-term was hard, but finally having a name for what I was experiencing allowed me to begin coping effectively. The diagnosis explained fatigue, mood swings, muscle aches, headaches, and the other ongoing symptoms that had often been minimized.
Almost two decades after that diagnosis, I still have difficult days. I’ve learned to honor my body when it needs rest, to manage stress intentionally, and to make food and movement choices that support my overall wellbeing. Those practices help prevent symptom flare-ups, but the uncertainty about long-term risks and the sense that treatment options were one-size-fits-all persisted.
So when experts began the process of changing the name from PCOS to polyendocrine metabolic ovarian syndrome, or PMOS, I felt unexpectedly hopeful. The new name acknowledges that this is a multisystem, metabolic and endocrine condition, not just a reproductive issue. For many of us who were told to simply take birth control or lose weight, that shift in emphasis matters. It reframes the condition as one that can affect many aspects of health across the lifespan, not only fertility.
Turning 40 recently sharpened my focus on prevention and personalized care. I decided to take more proactive steps — adjusting my diet, increasing activity where I can, and working with my clinician on medication options to manage weight and metabolic risk. I started a GLP-1 medication and have been careful to pair any pharmaceutical approach with sustainable lifestyle changes. The goal is not perfection, but a manageable strategy that reduces long-term risks and improves daily quality of life.
What gives me the most hope is the possibility that a change in name will prompt a change in practice. If PMOS leads clinicians to look beyond the ovaries, to screen for metabolic and endocrine issues earlier, and to tailor treatment to each person’s symptoms and risks, younger people might avoid the years of uncertainty I experienced. I want care that recognizes the whole person: body, mind, and life circumstances.
I still live with symptoms, but having a clearer diagnosis and more targeted conversations with healthcare providers has made a big difference. The move from PCOS to PMOS feels like an important step toward better understanding, better treatments, and more validation for everyone navigating this complex condition.
